Mycobacterium triplex pulmonary disease in immunocompetent host

Emerging Infectious Diseases

Volumn 10, Issue 10, 2004, Pages 1859-1862

  Piersimoni, Claudio ^a   Zitti, Piergiorgio ^a   Mazzarelli, Gianna ^b   Mariottini, Alessandro ^b   Nista, Domenico ^a   Zallocco, Diego ^a  

^a United Hospitals   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; LEVOFLOXACIN; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN;

ANTIMICROBIAL THERAPY; BACTERIAL GENE; BACTERIUM ISOLATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; LUNG DISEASE; MYCOBACTERIUM; MYCOBACTERIUM TRIPLEX; REVIEW;

EID: 4844226050     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1010.040217     Document Type: Review

References (18)

1. Primm TP, Lucero CA, Falkinham JO III. Health impacts of environmental mycobacteria. Clin Microbiol Rev. 2004;17:98-106.
2. Falkinham JO III. Mycobacterial aerosols and respiratory disease. Emerg Infect Dis. 2003;9:763-7.
3. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med. 1997;156:S1-25.
4. Floyd MM, Guthertz LS, Silcox VA, Duffey PS, Jang I, Desmond EP, et al. Characterization of an SAV organism and proposal of Mycobacterium triplex sp. nov. J Clin Microbiol. 1996;34:2963-7.
5. Selvarangan R, Whei-Kuo W, Trang TN, Carlson LDC, Wallis CK, Stiglich SK, et al. Characterization of a novel group of mycobacteria and proposal of Mycobacterium sherrisii sp. nov. J Clin Microbiol. 2004;42:52-9.
6. Springer B, Whei-Kuo W, Bodmer T, Haase G, Pfyffer GE, Kroppenstedt RM, et al. Isolation and characterization of a unique group of slowly growing mycobacteria: description of Mycobacterium lentiflavum sp. nov. J Clin Microbiol. 1996;34:1100-7.
7. Cingolani A, Sanguinetti M, Antinori A, Larocca LM, Ardito F, Posteraro B, et al. Disseminated mycobacteriosis caused by drug-resistant Mycobacterium tripex in a human immunodeficiency virus-infected patient during highly active antiretroviral therapy. Clin Infect Dis. 2000;31:177-9.
8. Hoff E, Sholtis M, Procop G, Sabella C, Goldfarb J, Willie R, et al. Mycobacterium tripex infection in a liver transplant patient. J Clin Microbiol. 2001;39:2033-4.
9. Zeller V, Nardi AL, Truffot-Pernot C, Sougakoff V, Stankoff B, Katlama C, et al. Disseminated infection with a mycobacterium related to Mycobacterium tripex with central nervous system involvement associated with AIDS. J Clin Microbiol. 2003;41:2785-7.
10. Metchock B, Nolte FS, Wallace RJ Jr. Mycobacterium. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 7th ed. Washington: ASM Press; 1999. p. 399-437.
11. Tortoli E, Mariottini A, Mazzarelli G. Evaluation of INNO-LiPA MYCOBACTERIA v2: improved reverse hybridization multiple DNA probe assay for mycobacterial identification. J Clin Microbiol. 2003;41:4418-20.
12. Tortoli E, Bartoloni A, Burrini, Mantella A, Simonetti MT. Utility of high performance liquid chromatography for identification of mycobacterial species rarely encountered in clinical laboratories. Eur J Clin Microbiol Infect Dis. 1995;14:240-3.
13. Harmsen D, Rothganger J, Singer C, Albert J, Frosch M. Intuitive hypertext-based molecular identification of microorganisms. Lancet. 1999;353:291.
14. Siddiqi SH, Heifets LB, Cynamon MH, Hooper NM, Laszlo A, Libonati JP, et al. Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates. J Clin Microbiol. 1993;31:2332-8.
15. Suomalainen S, Koukila-Kähkölä P, Brander E, Katila ML, Pilonen A, Paulin L, et al. Pulmonary infection by an unusual slowly growing nontuberculous mycobacterium. J Clin Microbiol. 2001;39:2668-71.
16. McMullan R, Xu J, Kelly M, Stanley T, Moore JE, Millar BC, et al. Mycobacterium triplex pulmonary infection in an immunocompetent patient. J Infect. 2002;44:263-4.
17. National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes. Approved standard M24-A. Wayne (PA): the Committee; 2003.
18. Heifets L. Dilemmas and realities in drug susceptibility testing of Mycobacterium avium-Mycobacterium intracellulare and other slowly growing nontuberculous mycobacteria. In: Heifets LB, editor. Drug susceptibility in the chemotherapy of mycobacterial infections. Boca Raton (FL): CRC Press; 1991. p. 123-46.